Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction | Zendy

AnneMarie Schjerning Olsen | Zendy; Emil Loldrup Fosbøl | Zendy; Jesper Lindhardsen | Zendy; Fredrik Folke | Zendy; Mette Charlot | Zendy; Christian Selmer | Zendy; Morten Lamberts | Zendy; Jes Olesen | Zendy; Lars Køber | Zendy; Peter Riis Hansen | Zendy; Christian TorpPedersen | Zendy; Gunnar Gislason | Zendy

Open Access

Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction

Author(s) -

AnneMarie Schjerning Olsen,

Emil Loldrup Fosbøl,

Jesper Lindhardsen,

Fredrik Folke,

Mette Charlot,

Christian Selmer,

Morten Lamberts,

Jes Olesen,

Lars Køber,

Peter Riis Hansen,

Christian TorpPedersen,

Gunnar Gislason

Publication year - 2011

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.110.004671

Subject(s) - medicine , hazard ratio , myocardial infarction , confidence interval , diclofenac , proportional hazards model , lower risk , aspirin , anesthesia

Despite the fact that nonsteroidal anti-inflammatory drugs (NSAIDs) are contraindicated among patients with established cardiovascular disease, many receive NSAID treatment for a short period of time. However, little is known about the association between NSAID treatment duration and risk of cardiovascular disease. We therefore studied the duration of NSAID treatment and cardiovascular risk in a nationwide cohort of patients with prior myocardial infarction (MI).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research